Toward more informative biomarker-based clinical trials in glioblastoma.
Sign Up to like & getrecommendations! Published in 2017 at "Neuro-oncology"
DOI: 10.1093/neuonc/nox063
Abstract: Given the significant advances using both targeted therapies and immunotherapies in other solid tumors, the therapeutic advances in glioblastoma (GBM) are particularly disappointing. One might think that an important factor is a lack of understanding… read more here.
Keywords: toward informative; trial; biomarker subtypes; biomarker ... See more keywords